277 related articles for article (PubMed ID: 26865616)
21. Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging.
Silverberg GD; Messier AA; Miller MC; Machan JT; Majmudar SS; Stopa EG; Donahue JE; Johanson CE
J Neuropathol Exp Neurol; 2010 Oct; 69(10):1034-43. PubMed ID: 20838242
[TBL] [Abstract][Full Text] [Related]
22. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
Storelli F; Billington S; Kumar AR; Unadkat JD
Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
[TBL] [Abstract][Full Text] [Related]
23. Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells.
Shubbar MH; Penny JI
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2314-2322. PubMed ID: 30048740
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human microsomal PGE2 synthase-1 reduces seizure-induced increases of P-glycoprotein expression and activity at the blood-brain barrier.
Soldner ELB; Hartz AMS; Akanuma SI; Pekcec A; Doods H; Kryscio RJ; Hosoya KI; Bauer B
FASEB J; 2019 Dec; 33(12):13966-13981. PubMed ID: 31638830
[TBL] [Abstract][Full Text] [Related]
25. Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain.
Swaminathan SK; Ahlschwede KM; Sarma V; Curran GL; Omtri RS; Decklever T; Lowe VJ; Poduslo JF; Kandimalla KK
J Cereb Blood Flow Metab; 2018 May; 38(5):904-918. PubMed ID: 28569090
[TBL] [Abstract][Full Text] [Related]
26. Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.
Hong L; Huang HC; Jiang ZF
Neurol Res; 2014 Mar; 36(3):276-82. PubMed ID: 24512022
[TBL] [Abstract][Full Text] [Related]
27. 1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells.
Durk MR; Chan GN; Campos CR; Peart JC; Chow EC; Lee E; Cannon RE; Bendayan R; Miller DS; Pang KS
J Neurochem; 2012 Dec; 123(6):944-53. PubMed ID: 23035695
[TBL] [Abstract][Full Text] [Related]
28. Evidence against a role of P-glycoprotein in the clearance of the Alzheimer's disease Aβ1-42 peptides.
Bello I; Salerno M
Cell Stress Chaperones; 2015 May; 20(3):421-30. PubMed ID: 25591827
[TBL] [Abstract][Full Text] [Related]
29. The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease.
Vogelgesang S; Warzok RW; Cascorbi I; Kunert-Keil C; Schroeder E; Kroemer HK; Siegmund W; Walker LC; Pahnke J
Curr Alzheimer Res; 2004 May; 1(2):121-5. PubMed ID: 15975076
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
31. P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations.
Chiu C; Miller MC; Monahan R; Osgood DP; Stopa EG; Silverberg GD
Neurobiol Aging; 2015 Sep; 36(9):2475-82. PubMed ID: 26159621
[TBL] [Abstract][Full Text] [Related]
32. Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease.
Qosa H; Abuznait AH; Hill RA; Kaddoumi A
J Alzheimers Dis; 2012; 31(1):151-65. PubMed ID: 22504320
[TBL] [Abstract][Full Text] [Related]
33. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
34. Distinct Uptake Kinetics of Alzheimer Disease Amyloid-
Sharda N; Ahlschwede KM; Curran GL; Lowe VJ; Kandimalla KK
J Pharmacol Exp Ther; 2021 Mar; 376(3):482-490. PubMed ID: 33303699
[TBL] [Abstract][Full Text] [Related]
35. Assessing the Impact of Lithium Chloride on the Expression of P-Glycoprotein at the Blood-Brain Barrier.
Newman SA; Pan Y; Short JL; Nicolazzo JA
J Pharm Sci; 2017 Sep; 106(9):2625-2631. PubMed ID: 28093288
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein.
Hartz AM; Madole EK; Miller DS; Bauer B
J Pharmacol Exp Ther; 2010 Aug; 334(2):467-76. PubMed ID: 20460386
[TBL] [Abstract][Full Text] [Related]
37. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
[TBL] [Abstract][Full Text] [Related]
38. Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood-Brain Barrier.
Zhou AL; Swaminathan SK; Salian VS; Wang L; Curran GL; Min HK; Lowe VJ; Kandimalla KK
Mol Pharm; 2024 May; 21(5):2176-2186. PubMed ID: 38625027
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimer's disease.
Abuznait AH; Cain C; Ingram D; Burk D; Kaddoumi A
J Pharm Pharmacol; 2011 Aug; 63(8):1111-8. PubMed ID: 21718295
[TBL] [Abstract][Full Text] [Related]
40. Human Herpesvirus 6A U4 Inhibits Proteasomal Degradation of the Amyloid Precursor Protein.
Tang T; Jia J; Garbarino E; Chen L; Ma J; Li P; Chen X; Wang L; Wen Y; Wang Y; Li L; Yao K; Tang H
J Virol; 2022 Feb; 96(4):e0168821. PubMed ID: 34878807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
